VTechWorks staff will be away for the winter holidays starting Tuesday, December 24, 2024, through Wednesday, January 1, 2025, and will not be replying to requests during this time. Thank you for your patience, and happy holidays!
 

Safety Benefits of a Carrier-implemented Sleep Apnea Program for Commercial Motor Vehicle Drivers

Simple item page
dc.contributor.authorMabry, J. Erinen
dc.contributor.authorGlenn, T. Laurelen
dc.contributor.authorSoccolich, Susan A.en
dc.contributor.authorHickman, Jeffrey S.en
dc.contributor.authorDurmer, Jeffreyen
dc.date.accessioned2022-10-14T15:54:12Zen
dc.date.available2022-10-14T15:54:12Zen
dc.date.issued2022-10-11en
dc.description.abstractThe Virginia Tech Transportation Institute (VTTI) collaborated with a leading third-party population sleep health provider, Fusion Health, and two for-hire carriers to perform an independent analysis of the safety benefits of two, carrier-implemented obstructive sleep apnea (OSA) programs for commercial motor vehicle (CMV) drivers (OSAFE). The research team obtained OSA diagnostic and treatment data from Fusion Health and safety and driver information from the participating carriers. The crash types assessed in the analysis included claims-only, on-road, and preventable crashes. To compare OSA-treated drivers to drivers without diagnosed OSA, a matched cohort approach was taken to include treated drivers and drivers without diagnosed OSA. Safety performance was investigated to explore crash rates before and during PAP treatment, crash rates by treatment adherence and average usage, and crash rates before and during treatment for drivers with a previous crash. The main findings from this study include the following: (1) high PAP adherence rates among OSA drivers, with more than 90% of drivers from both carriers meeting full-adherence requirements for PAP compliance; (2) support for the safety benefits of PAP treatment in CMV drivers who were OSA positive and demonstrated full adherence to treatment; (3) pronounced safety benefits for CMV drivers that experienced a crash prior to beginning PAP treatment; (4) a dose-response safety benefit of PAP use among drivers at Carrier A; and (5) for Carrier A drivers with full adherence to PAP, higher rates of claims-only and preventable crashes before and during treatment compared to similar control drivers. Given that fully compliant PAP treatment was associated with reductions in on-road and preventable crashes, carriers should focus on (1) identifying OSA drivers through effective screening programs, (2) providing PAP treatment, (3) monitoring PAP compliance, and (4) providing support to assist drivers in maintaining OSA compliance.en
dc.format.mimetypeapplication/pdfen
dc.identifier.urihttp://hdl.handle.net/10919/112169en
dc.language.isoenen
dc.publisherNational Surface Transportation Safety Center for Excellenceen
dc.relation.ispartofseriesNSTSCE;22-UI-111en
dc.rightsIn Copyright (InC)en
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subjecttransportation safetyen
dc.subjectCrash risken
dc.subjectCommercial motor vehicle (CMV)en
dc.subjectSleep apneaen
dc.titleSafety Benefits of a Carrier-implemented Sleep Apnea Program for Commercial Motor Vehicle Driversen
dc.typeReporten
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
NSTSCE_OSAFE_Final.pdf
Size:
1.25 MB
Format:
Adobe Portable Document Format
Description:
Report
Download
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.5 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

National Surface Transportation Safety Center for Excellence Reports (NSTSCE, VTTI)